There are more than one hundred clinical trials currently taking place in Nebraska. Jeff Trewhitt is the author of the report, “Pharmaceutical Clinical Trials in Nebraska” and says nearly everyone in the state benefits.
Biopharmaceutical research companies are conducting or have conducted nearly 2,000 clinical trials of new medicines in collaboration with the state’s medical schools, clinical research centers and hospitals since 1999. Of those, 1,019 target the nation’s six most debilitating chronic diseases of asthma, cancer, diabetes, heart disease, mental illness and stroke.
There are a number of economic benefits to Nebraska. The report shows that biopharmaceutical research companies are a source of jobs, tax revenue and research spending in Nebraska. Wages and benefits for employees whose jobs were supported by the biopharmaceutical sector resulted in about $33 million in federal taxation and $14.1 million in state taxes. Research companies generated $2.5-billion in goods and services to the state.
For those interested in learning more about clinical trials should talk to their health care provider. Many times they are aware of what is being conducted at hospitals, universities and other facilities. Patients can also use hospital and university websites to find the trials being conducted in their area.